TABLE 2.
Estimate | 95% CI | p Value | |
---|---|---|---|
ABAS-3 conceptual |
|
|
|
Slope: GTR |
1.29 |
−0.07 to 2.64 |
0.062 |
Slope: PR+RT |
−1.57 |
−3.30 to 0.16 |
0.074 |
Slope difference: GTR vs PR+RT |
2.86 |
0.66 to 5.05 |
0.012 |
ABAS-3 social |
|
|
|
Slope: GTR |
0.67 |
−1.74 to 3.08 |
0.553 |
Slope: PR+RT |
−1.64 |
−4.47 to 1.20 |
0.236 |
Slope difference: GTR vs PR+RT |
2.31 |
−1.41 to 6.03 |
0.203 |
ABAS-3 practical |
|
|
|
Slope: GTR |
2.11 |
−0.42 to 4.63 |
0.087 |
Slope: PR+RT |
−0.36 |
−3.47 to 2.75 |
0.791 |
Slope difference: GTR vs PR+RT |
2.47 |
−1.54 to 6.47 |
0.185 |
ABAS-3 GAC |
|
|
|
Slope: GTR |
1.72 |
0.18 to 3.27 |
0.030 |
Slope: PR+RT |
−0.82 |
−2.77 to 1.12 |
0.401 |
Slope difference: GTR vs PR+RT | 2.55 | 0.06 to 5.03 | 0.045 |
Estimates reported for each slope represent the increase/decrease in points per year on each ABAS-3 composite score by treatment group. Slope difference is the result of comparison of slopes between treatment groups on each ABAS-3 composite.